Recent years have seen an explosion of innovation in health care and life sciences. In 2023, the FDA approved the world’s first CRISPR therapy to treat sickle cell disease and a new treatment for Alzheimer’s disease. The advent of generative AI, digital devices and wearables has also opened new frontiers, driving advancements that redefine how we approach, develop and experience medical care.

Panel: How to Finance Health Innovation
Dr. Aiden Aceves, Insight Partners
Dr. Mira Chaurushiya, Westlake Village BioPartners
Stephen Chen, Scanwell / Becton Dickinson
Biren Mehta, Johnson & Johnson

Read more about the UCLA Anderson Healthcare Business Association’s annual Vitals conference:
[ Ссылка ]

#healthtech #AI #therapeutics

свернуть